Cochrane Abstracts
Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control Edited (no change to conclusions)
Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Insulin Monotherapy Compared With the Addition of Oral Glucose‐lowering Agents to Insulin for People With Type 2 Diabetes Already On Insulin Therapy and Inadequate Glycaemic Control Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438034/all/Insulin_monotherapy_compared_with_the_addition_of_oral_glucose���lowering_agents_to_insulin_for_people_with_type_2_diabetes_already_on_insulin_therapy_and_inadequate_glycaemic_control_Edited__no_change_to_conclusions_. Accessed 18 August 2022.
Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438034/all/Insulin_monotherapy_compared_with_the_addition_of_oral_glucose���lowering_agents_to_insulin_for_people_with_type_2_diabetes_already_on_insulin_therapy_and_inadequate_glycaemic_control_Edited__no_change_to_conclusions_. Accessed August 18, 2022.
Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438034/all/Insulin_monotherapy_compared_with_the_addition_of_oral_glucose���lowering_agents_to_insulin_for_people_with_type_2_diabetes_already_on_insulin_therapy_and_inadequate_glycaemic_control_Edited__no_change_to_conclusions_
Insulin Monotherapy Compared With the Addition of Oral Glucose‐lowering Agents to Insulin for People With Type 2 Diabetes Already On Insulin Therapy and Inadequate Glycaemic Control Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2022 August 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438034/all/Insulin_monotherapy_compared_with_the_addition_of_oral_glucose���lowering_agents_to_insulin_for_people_with_type_2_diabetes_already_on_insulin_therapy_and_inadequate_glycaemic_control_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control Edited (no change to conclusions)
ID - 438034
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438034/all/Insulin_monotherapy_compared_with_the_addition_of_oral_glucose���lowering_agents_to_insulin_for_people_with_type_2_diabetes_already_on_insulin_therapy_and_inadequate_glycaemic_control_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
